{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:37:09Z","timestamp":1777311429529,"version":"3.51.4"},"posted":{"date-parts":[[2026,4,27]]},"group-title":"In Review","reference-count":90,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,16]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>BACKGROUND<\/bold>\n                  Advances in omics technologies, such as epigenomics and metabolomics, provide novel insights into the biological mechanisms underlying Alzheimer's disease (AD). However, little is known how different omics layers interact and jointly relate to AD neuropathology.\n                  <bold>METHODS<\/bold>\n                  We performed a comprehensive single- and multi-omics analysis integrating genome-wide DNA methylation and high-resolution metabolomics data from 157 frontal cortex samples. We developed novel single and multi-omics profile scores (PS) for AD pathology, using a combination of machine learning, regression, and pathway analysis.\n                  <bold>RESULTS<\/bold>\n                  For the ABC score (Amyloid, Braak, CERAD) the PS of DNAm outperformed metabolomics-based PS (median R\u00b2: 0.11 vs. 0.04). Combining both omics layers with the best-performing multi-omics PS yielded a partial R\u00b2 of 0.15 for the ABC score independent of age, sex, race and socioeconomic factors. DNAm-specific pathways highlighted redox balance, immune activation, synaptic signaling, and lipid biosynthesis, whereas metabolomics-specific pathways emphasized inflammatory, hormonal, lipid, and energy metabolism. Notably, both omics layers converged on lipid metabolism and signal transduction as shared biological systems implicated in AD neuropathology.\n                  <bold>CONCLUSIONS<\/bold>\n                  Despite limited gains in predictive accuracy, integrative pathway and network analyses of DNAm and metabolomics PS converged on lipid metabolism and signal transduction, underscoring shared biological mechanisms and the value of multi-omics approaches for biological insight rather than prediction alone.\n                <\/p>","DOI":"10.21203\/rs.3.rs-9438710\/v1","type":"posted-content","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:39:32Z","timestamp":1777307972000},"source":"Crossref","is-referenced-by-count":0,"title":["Development and Application of Brain Tissue Based Multi-omics Profile Scores for Alzheimer's Disease"],"prefix":"10.21203","author":[{"given":"Timur","family":"Tug","sequence":"first","affiliation":[{"name":"TU Dortmund University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghai","family":"Liang","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Teschke","sequence":"additional","affiliation":[{"name":"TU Dortmund University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youran","family":"Tan","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marla","family":"Gearing","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Lah","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliza P.","family":"Wingo","sequence":"additional","affiliation":[{"name":"University of California, Davis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas S.","family":"Wingo","sequence":"additional","affiliation":[{"name":"University of California, Davis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lau","sequence":"additional","affiliation":[{"name":"Heinrich Heine University D\u00fcsseldorf"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Ickstadt","sequence":"additional","affiliation":[{"name":"TU Dortmund University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"H\u00fcls","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. Alzheimer's disease facts and figures. Alzheimers Dement. 2022;18:700\u201389. doi:10.1002\/alz.12638.","DOI":"10.1002\/alz.12638"},{"key":"ref2","unstructured":"2. Centers for Disease Control and Prevention. Alzheimer\u2019s Disease and Healthy Aging Data. 2023. https:\/\/www.cdc.gov\/aging\/agingdata."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Nandi A, Counts N, Br\u00f6ker J, Malik S, Chen S, Han R, et al. Cost of care for Alzheimer's disease and related dementias in the United States: 2016 to 2060. NPJ Aging. 2024;10:13. doi:10.1038\/s41514-024-00136-6.","DOI":"10.1038\/s41514-024-00136-6"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Long JM, Holtzman DM. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. 2019;179:312\u201339. doi:10.1016\/j.cell.2019.09.001.","DOI":"10.1016\/j.cell.2019.09.001"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science. 2002;298:789\u201391. doi:10.1126\/science.1074069.","DOI":"10.1126\/science.1074069"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, et al. Single-cell transcriptomic analysis of Alzheimer's disease. Nature. 2019;570:332\u20137. doi:10.1038\/s41586-019-1195-2.","DOI":"10.1038\/s41586-019-1195-2"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Dai X, Shen L. Advances and Trends in Omics Technology Development. Front Med (Lausanne). 2022;9:911861. doi:10.3389\/fmed.2022.911861.","DOI":"10.3389\/fmed.2022.911861"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Wilkins JM, Trushina E. Application of Metabolomics in Alzheimer's Disease. Front Neurol. 2017;8:719. doi:10.3389\/fneur.2017.00719.","DOI":"10.3389\/fneur.2017.00719"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Yuan Y, Zhao G, Zhao Y. Dysregulation of energy metabolism in Alzheimer's disease. J Neurol. 2024;272:2. doi:10.1007\/s00415-024-12800-8.","DOI":"10.1007\/s00415-024-12800-8"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Cleland NRW, Al-Juboori SI, Dobrinskikh E, Bruce KD. Altered substrate metabolism in neurodegenerative disease: new insights from metabolic imaging. J Neuroinflammation. 2021;18:248. doi:10.1186\/s12974-021-02305-w.","DOI":"10.1186\/s12974-021-02305-w"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Korczowska-\u0141\u0105cka I, Hur\u0142a M, Banaszek N, Kobylarek D, Szymanowicz O, Kozubski W, Dorszewska J. Selected Biomarkers of Oxidative Stress and Energy Metabolism Disorders in Neurological Diseases. Mol Neurobiol. 2023;60:4132\u201349. doi:10.1007\/s12035-023-03329-4.","DOI":"10.1007\/s12035-023-03329-4"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Zeng Y, Cao S, Li N, Tang J, Lin G. Identification of key lipid metabolism-related genes in Alzheimer's disease. Lipids Health Dis. 2023;22:155. doi:10.1186\/s12944-023-01918-9.","DOI":"10.1186\/s12944-023-01918-9"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. H\u00fcls A, Tan Y, Casey E, Li Z, Gearing M, Levey AI, et al. Metabolic dysregulation in Alzheimer's disease: A brain metabolomics approach. Alzheimers Dement. 2025;21:e70528. doi:10.1002\/alz.70528.","DOI":"10.1002\/alz.70528"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Besser LM, Kukull WA, Teylan MA, Bigio EH, Cairns NJ, Kofler JK, et al. The Revised National Alzheimer's Coordinating Center's Neuropathology Form-Available Data and New Analyses. J Neuropathol Exp Neurol. 2018;77:717\u201326. doi:10.1093\/jnen\/nly049.","DOI":"10.1093\/jnen\/nly049"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 2012;123:1\u201311. doi:10.1007\/s00401-011-0910-3.","DOI":"10.1007\/s00401-011-0910-3"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegener. 2019;14:32. doi:10.1186\/s13024-019-0333-5.","DOI":"10.1186\/s13024-019-0333-5"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","DOI":"10.1007\/BF00308809"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479\u201386. doi:10.1212\/WNL.41.4.479.","DOI":"10.1212\/WNL.41.4.479"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Thal DR, R\u00fcb U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58:1791\u2013800. doi:10.1212\/WNL.58.12.1791.","DOI":"10.1212\/WNL.58.12.1791"},{"key":"ref20","unstructured":"20. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2021."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. Pett L, Li Z, Abrishamcar S, Hodge K, Everson T, Christensen G, et al. The association between neighborhood deprivation and DNA methylation in an autopsy cohort. Aging (Albany NY). 2024;16:6694\u2013716. doi:10.18632\/aging.205764.","DOI":"10.18632\/aging.205764"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118\u201327. doi:10.1093\/biostatistics\/kxj037.","DOI":"10.1093\/biostatistics\/kxj037"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"23. Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363\u20139. doi:10.1093\/bioinformatics\/btu049.","DOI":"10.1093\/bioinformatics\/btu049"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"24. Guintivano J, Aryee MJ, Kaminsky ZA. A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression. Epigenetics. 2013;8:290\u2013302. doi:10.4161\/epi.23924.","DOI":"10.4161\/epi.23924"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"25. Maksimovic J, Gordon L, Oshlack A. SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol. 2012;13:R44. doi:10.1186\/gb-2012-13-6-r44.","DOI":"10.1186\/gb-2012-13-6-r44"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"26. Fortin J-P, Hansen KD. Reconstructing A\/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. Genome Biol. 2015;16:180. doi:10.1186\/s13059-015-0741-y.","DOI":"10.1186\/s13059-015-0741-y"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"27. Fortin J-P, Triche TJ, Hansen KD. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2017;33:558\u201360. doi:10.1093\/bioinformatics\/btw691.","DOI":"10.1093\/bioinformatics\/btw691"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"28. Fortin J-P, Labbe A, Lemire M, Zanke BW, Hudson TJ, Fertig EJ, et al. Functional normalization of 450k methylation array data improves replication in large cancer studies. Genome Biol. 2014;15:503. doi:10.1186\/s13059-014-0503-2.","DOI":"10.1186\/s13059-014-0503-2"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"29. Triche TJ, Weisenberger DJ, van den Berg D, Laird PW, Siegmund KD. Low-level processing of Illumina Infinium DNA Methylation BeadArrays. Nucleic Acids Res. 2013;41:e90. doi:10.1093\/nar\/gkt090.","DOI":"10.1093\/nar\/gkt090"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"30. Andrews SV, Ladd-Acosta C, Feinberg AP, Hansen KD, Fallin MD. \"Gap hunting\" to characterize clustered probe signals in Illumina methylation array data. Epigenetics Chromatin. 2016;9:56. doi:10.1186\/s13072-016-0107-z.","DOI":"10.1186\/s13072-016-0107-z"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"31. Go Y-M, Walker DI, Liang Y, Uppal K, Soltow QA, Tran V, et al. Reference Standardization for Mass Spectrometry and High-resolution Metabolomics Applications to Exposome Research. Toxicol Sci. 2015;148:531\u201343. doi:10.1093\/toxsci\/kfv198.","DOI":"10.1093\/toxsci\/kfv198"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"32. Ladva CN, Golan R, Liang D, Greenwald R, Walker DI, Uppal K, et al. Particulate metal exposures induce plasma metabolome changes in a commuter panel study. PLoS One. 2018;13:e0203468. doi:10.1371\/journal.pone.0203468.","DOI":"10.1371\/journal.pone.0203468"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. Liang D, Ladva CN, Golan R, Yu T, Walker DI, Sarnat SE, et al. Perturbations of the arginine metabolome following exposures to traffic-related air pollution in a panel of commuters with and without asthma. Environ Int. 2019;127:503\u201313. doi:10.1016\/j.envint.2019.04.003.","DOI":"10.1016\/j.envint.2019.04.003"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"34. Liang D, Moutinho JL, Golan R, Yu T, Ladva CN, Niedzwiecki M, et al. Use of high-resolution metabolomics for the identification of metabolic signals associated with traffic-related air pollution. Environ Int. 2018;120:145\u201354. doi:10.1016\/j.envint.2018.07.044.","DOI":"10.1016\/j.envint.2018.07.044"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"35. Ribbenstedt A, Ziarrusta H, Benskin JP. Development, characterization and comparisons of targeted and non-targeted metabolomics methods. PLoS One. 2018;13:e0207082. doi:10.1371\/journal.pone.0207082.","DOI":"10.1371\/journal.pone.0207082"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"36. Uppal K, Soltow QA, Strobel FH, Pittard WS, Gernert KM, Yu T, Jones DP. xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data. BMC Bioinformatics. 2013;14:15. doi:10.1186\/1471-2105-14-15.","DOI":"10.1186\/1471-2105-14-15"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"37. Yu T, Park Y, Johnson JM, Jones DP. apLCMS\u2013adaptive processing of high-resolution LC\/MS data. Bioinformatics. 2009;25:1930\u20136. doi:10.1093\/bioinformatics\/btp291.","DOI":"10.1093\/bioinformatics\/btp291"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"38. Kind AJH, Buckingham WR. Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas. N Engl J Med. 2018;378:2456\u20138. doi:10.1056\/NEJMp1802313.","DOI":"10.1056\/NEJMp1802313"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"39. Choi SW, Mak TS-H, O'Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc. 2020;15:2759\u201372. doi:10.1038\/s41596-020-0353-1.","DOI":"10.1038\/s41596-020-0353-1"},{"key":"ref40","unstructured":"40. Mayer M. missRanger: Fast Imputation of Missing Values; 2024."},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"41. Everitt BS, Landau S, Leese M, Stahl D. Cluster Analysis. 5th ed. Chichester, UK: Wiley; 2011.","DOI":"10.1002\/9780470977811"},{"key":"ref42","unstructured":"42. Coombes KR. ClassDiscovery: Classes and Methods for Class Discovery with Microarrays or Proteomics; 2024."},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"43. Langfelder P, Horvath S. Fast R Functions for Robust Correlations and Hierarchical Clustering. J. Stat. Soft. 2012. doi:10.18637\/jss.v046.i11.","DOI":"10.18637\/jss.v046.i11"},{"key":"ref44","unstructured":"44. Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K. cluster: Cluster Analysis Basics and Extensions; 2023."},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"45. Wurm MJ, Rathouz PJ, Hanlon BM. Regularized Ordinal Regression and the ordinalNet R Package. J Stat Softw 2021. doi:10.18637\/jss.v099.i06.","DOI":"10.18637\/jss.v099.i06"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"46. B\u00fchlmann P, Hothorn T. Boosting Algorithms: Regularization, Prediction and Model Fitting. Statist. Sci. 2007. doi:10.1214\/07-STS242.","DOI":"10.1214\/07-STS242"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"47. Lau M, Schikowski T, Schwender H. logicDT: a procedure for identifying response-associated interactions between binary predictors. Mach Learn. 2024;113:933\u201392. doi:10.1007\/s10994-023-06488-6.","DOI":"10.1007\/s10994-023-06488-6"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"48. Wright MN, Ziegler A. ranger : A Fast Implementation of Random Forests for High Dimensional Data in C\u2009+\u2009+\u2009and R. J. Stat. Soft. 2017. doi:10.18637\/jss.v077.i01.","DOI":"10.18637\/jss.v077.i01"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"49. Janitza S, Celik E, Boulesteix A-L. A computationally fast variable importance test for random forests for high-dimensional data. Adv Data Anal Classif. 2018;12:885\u2013915. doi:10.1007\/s11634-016-0276-4.","DOI":"10.1007\/s11634-016-0276-4"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"50. Teschke S, Ickstadt K, Munteanu A. Detecting Interactions in High-Dimensional Data Using Cross Leverage Scores. Biom J. 2024;66:e70014. doi:10.1002\/bimj.70014.","DOI":"10.1002\/bimj.70014"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"51. Simon N, Friedman J, Hastie T, Tibshirani R. A Sparse-Group Lasso. Journal of Computational and Graphical Statistics. 2013;22:231\u201345. doi:10.1080\/10618600.2012.681250.","DOI":"10.1080\/10618600.2012.681250"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"52. McCullagh P. Regression Models for Ordinal Data. Journal of the Royal Statistical Society. Series B (Methodological). 1980;42:109\u201342.","DOI":"10.1111\/j.2517-6161.1980.tb01109.x"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"53. Phipson B, Maksimovic J, Oshlack A. missMethyl: an R package for analysing methylation data from Illuminas HumanMethylation450 platform. Bioinformatics. 2015.","DOI":"10.1093\/bioinformatics\/btv560"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"54. Maksimovic J, Gordon L, Oshlack A. Removing unwanted variation in a differential methylation analysis of Illumina HumanMethylation450 array data. Nucleic Acids Res. 2015.","DOI":"10.1101\/019042"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"55. Phipson B, Oshlack A. DiffVar: A new method for detecting differential variability with application to methylation in cancer and aging. Genome Biol 2014. doi:10.1186\/s13059-014-0465-4.","DOI":"10.1101\/008847"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"56. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330. doi:10.1093\/nar\/28.1.27.","DOI":"10.1093\/nar\/28.1.27"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"57. Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28:1947\u201351. doi:10.1002\/pro.3715.","DOI":"10.1002\/pro.3715"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"58. Kanehisa M, Furumichi M, Sato Y, Matsuura Y, Ishiguro-Watanabe M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 2025;53:D672-D677. doi:10.1093\/nar\/gkae909.","DOI":"10.1093\/nar\/gkae909"},{"key":"ref59","unstructured":"59. Tianwei Yu TY. metapone: Bioconductor; 2021."},{"key":"ref60","unstructured":"60. Fisher RA. Statistical Methods for Research Workers. Edinburgh: Oliver & Boyd; 1925."},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"61. Loughin TM. A systematic comparison of methods for combining p-values from independent tests. Computational Statistics & Data Analysis. 2004;47:467\u201385. doi:10.1016\/j.csda.2003.11.020.","DOI":"10.1016\/j.csda.2003.11.020"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"62. Argelaguet R, Velten B, Arnol D, Dietrich S, Zenz T, Marioni JC, et al. Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets. Mol Syst Biol. 2018;14:e8124. doi:10.15252\/msb.20178124.","DOI":"10.15252\/msb.20178124"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"63. Farrer LA. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease. JAMA. 1997;278:1349. doi:10.1001\/jama.1997.03550160069041.","DOI":"10.1001\/jama.1997.03550160069041"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"64. Grimm MOW, Michaelson DM, Hartmann T. Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention. J Lipid Res. 2017;58:2083\u2013101. doi:10.1194\/jlr.R076331.","DOI":"10.1194\/jlr.R076331"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"65. Penke B, Paragi G, Gera J, Berkecz R, Kov\u00e1cs Z, Crul T, V\u00cdgh L. The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View. Curr Alzheimer Res. 2018;15:1191\u2013212. doi:10.2174\/1567205015666180911151716.","DOI":"10.2174\/1567205015666180911151716"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"66. He X, Huang Y, Li B, Gong C-X, Schuchman EH. Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol Aging. 2010;31:398\u2013408. doi:10.1016\/j.neurobiolaging.2008.05.010.","DOI":"10.1016\/j.neurobiolaging.2008.05.010"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"67. Butterfield DA, Perluigi M, Reed T, Muharib T, Hughes CP, Robinson RAS, Sultana R. Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. Antioxid Redox Signal. 2012;17:1610\u201355. doi:10.1089\/ars.2011.4109.","DOI":"10.1089\/ars.2011.4109"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"68. Yin F. Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J. 2023;290:1420\u201353. doi:10.1111\/febs.16344.","DOI":"10.1111\/febs.16344"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"69. Fabelo N, Mart\u00edn V, Mar\u00edn R, Moreno D, Ferrer I, D\u00edaz M. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP\/BACE1 interactions. Neurobiol Aging. 2014;35:1801\u201312. doi:10.1016\/j.neurobiolaging.2014.02.005.","DOI":"10.1016\/j.neurobiolaging.2014.02.005"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"70. OLIVIER J-L. Arachidonic acid in Alzheimer's disease. J Neurol Neuromedicine. 2016;1:1\u20136. doi:10.29245\/2572.942X\/2016\/9.1086.","DOI":"10.29245\/2572.942X\/2016\/9.1086"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"71. Grimm MOW, Haupenthal VJ, Rothhaar TL, Zimmer VC, Gr\u00f6sgen S, Hundsd\u00f6rfer B, et al. Effect of Different Phospholipids on \u03b1-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer's Disease. Int J Mol Sci. 2013;14:5879\u201398. doi:10.3390\/ijms14035879.","DOI":"10.3390\/ijms14035879"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"72. Kumari S, Dhapola R, Reddy DH. Apoptosis in Alzheimer's disease: insight into the signaling pathways and therapeutic avenues. Apoptosis. 2023;28:943\u201357. doi:10.1007\/s10495-023-01848-y.","DOI":"10.1007\/s10495-023-01848-y"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"73. Tenner AJ. Complement-Mediated Events in Alzheimer's Disease: Mechanisms and Potential Therapeutic Targets. J Immunol. 2020;204:306\u201315. doi:10.4049\/jimmunol.1901068.","DOI":"10.4049\/jimmunol.1901068"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"74. Clarke JR, Ribeiro FC, Frozza RL, Felice FG de, Lourenco MV. Metabolic Dysfunction in Alzheimer's Disease: From Basic Neurobiology to Clinical Approaches. J Alzheimers Dis. 2018;64:S405-S426. doi:10.3233\/JAD-179911.","DOI":"10.3233\/JAD-179911"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"75. Kan MJ, Lee JE, Wilson JG, Everhart AL, Brown CM, Hoofnagle AN, et al. Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease. J Neurosci. 2015;35:5969\u201382. doi:10.1523\/JNEUROSCI.4668-14.2015.","DOI":"10.1523\/JNEUROSCI.4668-14.2015"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"76. Pike CJ, Carroll JC, Rosario ER, Barron AM. Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol. 2009;30:239\u201358. doi:10.1016\/j.yfrne.2009.04.015.","DOI":"10.1016\/j.yfrne.2009.04.015"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"77. Chang T-Y, Yamauchi Y, Hasan MT, Chang C. Cellular cholesterol homeostasis and Alzheimer's disease. J Lipid Res. 2017;58:2239\u201354. doi:10.1194\/jlr.R075630.","DOI":"10.1194\/jlr.R075630"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"78. Va\u0148kov\u00e1 M, Vel\u00edkov\u00e1 M, Vejra\u017ekov\u00e1 D, V\u010del\u00e1k J, Luk\u00e1\u0161ov\u00e1 P, Rusina R, et al. The Role of Steroidomics in the Diagnosis of Alzheimer's Disease and Type 2 Diabetes Mellitus. Int J Mol Sci 2023. doi:10.3390\/ijms24108575.","DOI":"10.3390\/ijms24108575"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"79. Ehrenreich H, Degner D, Meller J, Brines M, B\u00e9h\u00e9 M, Hasselblatt M, et al. Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry. 2004;9:42\u201354. doi:10.1038\/sj.mp.4001442.","DOI":"10.1038\/sj.mp.4001442"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"80. La Monte SM de. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res. 2012;9:35\u201366. doi:10.2174\/156720512799015037.","DOI":"10.2174\/156720512799015037"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"81. Cunha RA. Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity. Neurochem Int. 2008;52:65\u201372. doi:10.1016\/j.neuint.2007.06.026.","DOI":"10.1016\/j.neuint.2007.06.026"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"82. Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M. Alzheimer's disease: clinical trials and drug development. Lancet Neurol. 2010;9:702\u201316. doi:10.1016\/S1474-4422(10)70119-8.","DOI":"10.1016\/S1474-4422(10)70119-8"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"83. Bahado-Singh RO, Vishweswaraiah S, Turkoglu O, Graham SF, Radhakrishna U. Alzheimer's Precision Neurology: Epigenetics of Cytochrome P450 Genes in Circulating Cell-Free DNA for Disease Prediction and Mechanism. Int J Mol Sci 2023. doi:10.3390\/ijms24032876.","DOI":"10.3390\/ijms24032876"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"84. Buto PT, Wang J, La Joie R, Zimmerman SC, Glymour MM, Ackley SF, et al. Genetic risk score for Alzheimer's disease predicts brain volume differences in mid and late life in UK biobank participants. Alzheimers Dement. 2024;20:1978\u201387. doi:10.1002\/alz.13610.","DOI":"10.1002\/alz.13610"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"85. Nagaraj S, Duong TQ. Deep Learning and Risk Score Classification of Mild Cognitive Impairment and Alzheimer's Disease. J Alzheimers Dis. 2021;80:1079\u201390. doi:10.3233\/JAD-201438.","DOI":"10.3233\/JAD-201438"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"86. Leonenko G, Baker E, Stevenson-Hoare J, Sierksma A, Fiers M, Williams J, et al. Identifying individuals with high risk of Alzheimer's disease using polygenic risk scores. Nat Commun. 2021;12:4506. doi:10.1038\/s41467-021-24082-z.","DOI":"10.1038\/s41467-021-24082-z"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"87. Wang Z, Tang Z, Zhu Y, Pettigrew C, Soldan A, Gross A, Albert M. AD risk score for the early phases of disease based on unsupervised machine learning. Alzheimers Dement. 2020;16:1524\u201333. doi:10.1002\/alz.12140.","DOI":"10.1002\/alz.12140"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"88. Koetsier J, Cavill R, Reijnders R, Harvey J, Homann J, Kouhsar M, et al. Blood-based multivariate methylation risk score for cognitive impairment and dementia. Alzheimers Dement. 2024;20:6682\u201398. doi:10.1002\/alz.14061.","DOI":"10.1002\/alz.14061"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"89. Cary GA, Wiley JC, Gockley J, Keegan S, Amirtha Ganesh SS, Heath L, et al. Genetic and multi-omic risk assessment of Alzheimer's disease implicates core associated biological domains. Alzheimers Dement (N Y). 2024;10:e12461. doi:10.1002\/trc2.12461.","DOI":"10.1002\/trc2.12461"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"90. Liu S, Zhong H, Zhu J, Wu L. Identification of blood metabolites associated with risk of Alzheimer's disease by integrating genomics and metabolomics data. Mol Psychiatry. 2024;29:1153\u201362. doi:10.1038\/s41380-023-02400-9.","DOI":"10.1038\/s41380-023-02400-9"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9438710\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9438710\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:42:10Z","timestamp":1777308130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9438710\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":90,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9438710\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,4,27]]},"subtype":"preprint"}}